Introduction to Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop
If you are looking for information about Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop, you have come to the right place. Jochem Gokemeijer, PhD. - Pre-clinical
Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop Comprehensive Overview
Peter Marks, MD. PhD. – Welcome Remarks. Lora Hamuro, PhD. - Quantitative Morten Nielsen, PhD. - The use of HLA class II antigen presentation prediction in the context of
Brandon Dekosky, PhD. - Exploring Personalization of Human Immune Responses with High-Throughput Immune Receptor Data.
Summary & Highlights for Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop
- Malachi Griffith, PhD. - Bioinformatics and immunogenomics
- Guangping Gao, PhD. - Vector-related
- Richard White, PhD. and Sophie Rhodes, Ph.D - Using Epidemiological and Immunostimulation/Immunodynamic
- Peter Gilbert, PhD. - Learning Immune Correlates of Protection from Vaccine Efficacy Trials.
- Andrzej Kierzek, PhD. - Quantitative Systems Pharmacology to predicting and managing impact of
We hope this detailed breakdown of Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop was helpful.